People with obesity treated with a novel GIP/GLP-1 receptor agonist, tirzepatide, lost about 52 pounds on average, according to results of a new study that were published [...]
Have high cholesterol? You’re not alone. The problem affects some 95 million Americans, according to Centers for Disease Control and Prevention, and has been linked to [...]